Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Editas Medicine (EDIT) Misses Q4 EPS by 9c
March 6, 2018 4:14 PM ESTEditas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.84), $0.09 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $3.67 million versus the consensus estimate of $4.13 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More